Investor mix
6 investors on record; lead investors include Alpha Wave Global, Jeito, Arch Venture Partners, Monograph; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 2 | 33% |
| Other / undisclosed | 1 | 17% |
Developer of precision medicines for autoimmune and inflammatory diseases
6 investors on record; lead investors include Alpha Wave Global, Jeito, Arch Venture Partners, Monograph; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 2 | 33% |
| Other / undisclosed | 1 | 17% |